On February 17th, Xu Renbiao, member of the Standing Committee of Taizhou Municipal Party Committee and Secretary of Wenling Municipal Party Committee, visited Wanbangde Pharmaceutical to investigate and guide the work related to the resumption of work and production during the prevention and control of the new coronavirus pneumonia epidemic and the prevention and control of the epidemic.
Mr. Xu Renbiao, the secretary of Wanbangde Pharmaceutical, understood in detail the epidemic prevention and control measures and the situation of resumption of work and production of the enterprise, and inquired carefully about the difficulties and problems faced by the enterprise at present. "Where do the workers who are currently resuming work come from, and how do the foreign workers plan to return to work?" "Are protective materials such as masks sufficient?"
"What measures have been taken to resume work?" Secretary Xu Renbiao and Chairman Zhao Shouming had an in-depth conversation.
Mr. Zhao Shouming, Chairman of the Board of Directors of Wanbangde Pharmaceutical, made a report on the related issues. Wanbangde Pharmaceutical has gradually resumed production since February 10th, and up to now, 30% of the total employees, all of whom are of Wenling nationality, have resumed work. The employees who are more concentrated in the source of foreign provinces, the company will take them back in batches by chartered buses and place them in hotels and some staff dormitories for isolation and observation. He said, in order to do a good job during the epidemic prevention and control of the enterprise back to work and production, the company introduced the epidemic prevention and control work program, the establishment of a new coronavirus infection pneumonia epidemic prevention and control work leading group. By the company's chairman of the board of directors as the leader, members of the leadership team as deputy leader, each sub-line deputy general manager and the heads of departments, workshop directors, key positions as members, with clear responsibilities, responsible for doing a good job in the company's epidemic prevention and control and emergency response work. In order to protect the staff, the company set up staff health records, the implementation of "one person, one file" management, and from the protective measures, staff epidemic prevention and control knowledge training, epidemic prevention and control of knowledge propaganda, temperature monitoring, boxed lunches, isolation and monitoring, strict supervision, etc., one hand on the prevention of the epidemic, and the other hand on the production, so as to achieve the production of epidemic prevention and control of both. At this stage, the company has stocked a number of medical masks and a number of disinfectant, alcohol and other protective materials.
Secretary Xu Renbiao emphasized that in the face of major epidemics, Wanbangde Pharmaceutical should play a pioneering role as a listed company, strictly implement the main responsibility of prevention and control, and take the life and health of employees as the primary goal. The resumption of work and production should ensure the implementation of prevention and control measures in place, personnel information check in place, internal management in place, protective materials in place, and should regularly carry out disinfection of production workshops, office buildings, staff restaurants, staff dormitories and other areas, to enhance employees' self-protection awareness, and to ensure that the risk during the epidemic is always within the controllable range.
Afterwards, Secretary Xu Renbiao highly praised Wanbangde for fulfilling its social responsibility and dedicating love during the epidemic prevention and control period, and utilizing overseas market channels to urgently purchase 78,500 N95 masks and more than 100 temperature measuring guns to help Taizhou and Wenling cities to fight against the epidemic, and hoped that Wanbangde Pharmaceutical would, as always, devote itself to social and public welfare undertakings and show its corporate responsibility in the future development. At the same time, he hoped that Wanbangde Pharmaceutical would, as always, devote itself to the public welfare and show its corporate responsibility in its future development.
Secretary Xu Renbiao also inquired carefully about what Wanbangde Pharmaceutical had done in the research and development of combating the new coronavirus pneumonia epidemic. Mr. Zhao Shouming, Chairman of the Board of Directors of Wanbangde Pharmaceutical, introduced that on February 13th, Zhejiang Food and Drug Administration and Zhejiang Provincial Health Commission organized an expert review and agreed that Wanbangde Bromohexine Hydrochloride Tablets should carry out emergency clinical scientific research on the treatment of new coronavirus-infected pneumonia and innovative application research, and that the project has been urgently launched by the Affiliated Hospital of Wenzhou Medical University, with full cooperation from Wanbangde Pharmaceutical, and that the relevant work has been fully coordinated. Pharmaceutical fully cooperate with the relevant drug research work is being advanced in an orderly manner. Secretary Xu Renbiao urged the enterprise to make every second count to carry out the clinical research and innovative application of the new coronavirus infection in the pneumonia epidemic, and make contributions to win the battle against the epidemic.
Secretary Xu Renbiao on the problems encountered in the development of the industry put forward by the enterprise, the scene requires the relevant departments to set up a task force to optimize the approval process, Wanbangde related projects to implement a person in charge of good service, to help coordinate and solve the difficulties and problems encountered in the development of the enterprise.